Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation ...

ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It ...

To pave the way for the launch of Oxbryta, Pfizer’s GBT unit approached Riester Rx to conduct research and develop a market-shaping campaign to increase awareness of sickle cell disease.

“The need for effective therapeutic options for patients with sickle cell disease has become even more urgent due to the recent withdrawal of OXBRYTA ® globally. Based on the initial data generated in ...

The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode lottery". Nathan, 16, from Northampton, suffers from chronic pain and takes ...